Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Clinical trial NCT05676710 · COMPLETED
Trial details
- NCT number
- NCT05676710
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2024-01-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.